Author

Edyta Korbut

INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP
INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP

INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP
INHIBITORY EFFECT OF PHARMACOLOGICALLY-DERIVED OR ENDOGENOUSLY PRODUCED HYDROGEN SULFIDE (H2S) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA THROUGH IL-1BETA/COX-2/PGE2 PATHWAY LOOP

Edyta Korbut  et al.

HYDROGEN SULFIDE SIGNALING IN GERD-INDUCED MTOR-DEPENDENT PALIGENOSIS: IMPLICATION FOR BARRETT'S ESOPHAGUS PATHOGENESIS
HYDROGEN SULFIDE SIGNALING IN GERD-INDUCED MTOR-DEPENDENT PALIGENOSIS: IMPLICATION FOR BARRETT'S ESOPHAGUS PATHOGENESIS

Edyta Korbut  et al.

INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING
INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING

Edyta Korbut  et al.

CONTRIBUTION OF ENZYMATIC ACTIVITY OF HEME OXYGENASE (HMOX) AND ITS BYPRODUCT, CARBON MONOXIDE (CO) IN BARRETT'S METAPLASIA DEVELOPMENT
CONTRIBUTION OF ENZYMATIC ACTIVITY OF HEME OXYGENASE (HMOX) AND ITS BYPRODUCT, CARBON MONOXIDE (CO) IN BARRETT'S METAPLASIA DEVELOPMENT

Edyta Korbut  et al.

HYDROGEN SULFIDE (H2S)-RELEASING AP-39 MODULATES GASTRIC MUCOSAL MITOCHONDRIAL ACTIVITY PREVENTING THE OXIDATIVE ISCHEMIA/REPERFUSION (I/R)-INDUCED GASTRIC MUCOSAL INJURY
HYDROGEN SULFIDE (H2S)-RELEASING AP-39 MODULATES GASTRIC MUCOSAL MITOCHONDRIAL ACTIVITY PREVENTING THE OXIDATIVE ISCHEMIA/REPERFUSION (I/R)-INDUCED GASTRIC MUCOSAL INJURY

Edyta Korbut  et al.

MITOCHONDRIA-TARGETED DELIVERY OF HYDROGEN SULFIDE (H2S)-PRODRUG COUNTERACTS GASTROTOXICITY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. INVOLVEMENT OF HEME OXYGENASE PATHWAY
MITOCHONDRIA-TARGETED DELIVERY OF HYDROGEN SULFIDE (H2S)-PRODRUG COUNTERACTS GASTROTOXICITY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. INVOLVEMENT OF HEME OXYGENASE PATHWAY

Edyta Korbut  et al.

Item 1 - 7 / 7
1